Contact: Mr. Huang
WhatsApp: +86 137 8779 4286
Mob:+86 151 1623 5351
Wechat:+86 151 1623 5351
Email:derrickguo@sh-qixin.cn
Address: Building, Jinsha River Road, Zhen Xin Street, JiadingDistrict, Shanghai, China.
Website:www.sh-qixin.cn, www.qixinchemicals.com
Heterogeneity reactions occur in a small number of patients and are often related to genetic factors. The sensitivity to certain drug abnormalities caused by congenital inheritance is basically consistent with the inherent pharmacological effects of drugs. Most of it is caused by the lack of certain enzymes in the body, which hinders the metabolism of drugs in the body. If chloramphenicol and amphotericin B enter red blood cells, they can transform hemoglobin into denatured hemoglobin; For patients with normal enzyme systems, such reactions will not occur after taking medication.
4. Double infection
High doses or long-term use of antibiotics, especially broad-spectrum antibiotics, can lead to the growth and reproduction of other non sensitive bacteria when sensitive bacteria are killed or suppressed. The bacteria that cause new infections can be parasitic bacteria that are normally harmless to the body. Due to changes in the bacterial population, other harmless bacteria that can inhibit the growth of the bacteria are suppressed by drugs and transformed into pathogenic bacteria, or they can also be drug-resistant strains of the primary infection bacteria. The secondary infections that are more likely to occur when using broad-spectrum antibiotics include: Clostridium difficile enteritis, fungal enteritis, oral fungal infection, candida albicans vaginitis, etc.
As for the adverse reactions caused by antibiotics, it has been mentioned earlier that everyone must pay attention to the dosage and method of use when using antibiotics to avoid any impact on the body. Shanghai Qixin New Materials Technology Co., Ltd. was established in 2016 and is located in Shanghai, China. It is a high-tech enterprise dedicated to the development of new materials, process optimization, and the research and development of pharmaceutical intermediates and reagents. Its main businesses include 7-amino-3-chloromethyl-2-cephem-2-carboxylic acid p-methoxybenzyl ester hydrochloric acid (CAS: 113479-65-5), Parylene F, Parylene F (VT-4), and Cefnitrothiophene, At the beginning of its establishment, companies such as Nitrocefin have regarded technological innovation and research and development capabilities as their core competitiveness, and are determined to provide customers with good products and technical services with price and technological advantages.
Shanghai QIXIN New Materials Technology Co., Ltd
Contact:Mr. Huang
Mob: +86 151 1623 5351
Address:Room J317, Building 2, No. 3131 Jinshajiang Road, Zhenxin Street, Jiading District, Shanghai, China